BKD
Brookdale Senior Living Inc.
BKD offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over BKD overall, supported by stronger modeled upside and lower modeled downside.
BKD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
BKD's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BKD PE Valuation
BKD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 460x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BKD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BKD to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BKD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.17 | +$1.14 |
| Q2 2026 | -$0.59 | +$0.46 |
| Q1 2026 | -$0.87 | +$0.17 |
| Q4 2025 | -$1.12 | -$0.23 |
| Q3 2025 | -$1.31 | -$0.39 |
| Q2 2025 | -$1.05 | -$0.13 |
| Q1 2025 | -$1.04 | -$0.27 |
| Q4 2024 | -$0.89 | -$0.05 |
BKD is still losing money, but far less than before: $0.17 per share over the past year, against $2.15 at its worst in early 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over BKD on earnings quality, reporting a profit while its opponent remains loss making.
BKD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $712.1M | -12% |
| Q2 2026 | $718.6M | -12% |
| Q1 2026 | $764.9M | -6% |
| Q4 2025 | $754.1M | -3.4% |
| Q3 2025 | $813.2M | +3.7% |
| Q2 2025 | $812.9M | +4.6% |
| Q1 2025 | $813.9M | +4% |
| Q4 2024 | $780.9M | +3.5% |
BKD's revenue has slid since its 2020 peak: $712M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | 12% | +10 points |
| Q1 2026 | 6.8% | +3.1 points |
| Q4 2025 | 3% | +3.3 points |
| Q3 2025 | -6.6% | -7.9 points |
| Q2 2025 | 1.8% | -0.6 points |
| Q1 2025 | 3.6% | +1.2 points |
| Q4 2024 | -0.3% | +2.9 points |
BKD's operating margin was 5.8% last quarter, up 12 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over BKD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over BKD on profitability, with a higher operating margin.
BKD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $25.7M | -26% |
| Q2 2026 | $43.5M | +49% |
| Q1 2026 | -$25.6M | -$7.2M |
| Q4 2025 | -$29.1M | -$24M |
| Q3 2025 | $34.9M | +204% |
| Q2 2025 | $29.1M | +610% |
| Q1 2025 | -$18.4M | +$27.1M |
| Q4 2024 | -$5.1M | +$24.1M |
BKD has burned cash in most quarters: $15M over the past year, down 64% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
BKD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.0x | High |
| Q2 2026 | 9.1x | High |
| Q1 2026 | 10.6x | High |
| Q4 2025 | 10.7x | High |
| Q3 2025 | 10.9x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 9.6x | High |
| Q4 2024 | 9.2x | High |
BKD's net debt is about 8.0 years of its operating earnings (EBITDA), down from 11 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over BKD on leverage, with a lower net debt burden relative to earnings.
BKD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 6.9 | Oversold |
BKD's weekly RSI is 29 (oversold) and its Stochastic is 7 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BKD PE vs Healthcare Sector
| Metric | BKD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BKD has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BKD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.1 | 11% below |
| 20 week MA | $12.1 | 26% below |
| 50 week MA | $12.8 | 30% below |
| 100 week MA | $9.91 | 9.6% below |
| 200 week MA | $7.54 | 19% above |
BKD has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BKD on trend strength, trading above more of its moving averages.
BKD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.01 | $4.21 | -40% |
| 2021 | $4.21 | $5.17 | +23% |
| 2022 | $5.17 | $2.71 | -48% |
| 2023 | $2.71 | $5.82 | +115% |
| 2024 | $5.82 | $5.07 | -13% |
| 2025 | $5.07 | $10.9 | +115% |
| 2026 YTD | $10.9 | $8.96 | -18% |
BKD's yearly returns have swung widely, from +115% in 2025 to −48% in 2022. It's down 18% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BKD on returns for 2026, with the stronger performance.